//NBM ANNOUNCES RECEIVING INVENTION PATENT, TITLED “PRENYLFLAVANONE COMPOUNDS FOR MODULATING DIABETES”, FROM ISRAELI’S PATENT OFFICE

NBM ANNOUNCES RECEIVING INVENTION PATENT, TITLED “PRENYLFLAVANONE COMPOUNDS FOR MODULATING DIABETES”, FROM ISRAELI’S PATENT OFFICE

The Israeli’s Patent Office approved the application of “PRENYLFLAVANONE COMPOUNDS FOR MODULATING DIABETES” from NBM for an invention patent with the certificate No. 231754. Prenylflavanone compounds have been used in NBM’s product, SugarBless, for blood sugar control.

2018-05-25T18:39:44+00:00 2018 / 05 / 18|Categories: News|Tags: |